Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
---|---|---|---|---|---|---|
Q3 2024 | 179 | 695,519 | EMR, GLW, IBM, TSM | 13F-HR | 11/8/2024 | 000091953024000004 |
Q2 2024 | 179 | 655,474 | EMR, GLW, TSM, IBM | 13F-HR | 8/8/2024 | 000091953024000003 |
Q1 2024 | 174 | 651,817 | EMR, GLW, IBM, TSM | 13F-HR | 5/6/2024 | 000091953024000002 |
Q4 2023 | 169 | 630,462 | EMR, GLW, IBM, OGE | 13F-HR | 1/31/2024 | 000091953024000001 |
Q3 2023 | 173 | 611,335 | EMR, GLW, BMY, CSCO | 13F-HR | 11/1/2023 | 000091953023000004 |
Q2 2023 | 177 | 648,139 | EMR, GLW, BMY, PFE | 13F-HR | 8/21/2023 | 000091953023000003 |
Q1 2023 | 177 | 642,976 | EMR, GLW, BMY, PFE | 13F-HR | 5/5/2023 | 000091953023000002 |
Q4 2022 | 169 | 627,196 | EMR, PFE, BMY, GLW | 13F-HR | 2/8/2023 | 000091953023000001 |
Q3 2022 | 157 | 571,531 | EMR, BMY, PFE, GLW | 13F-HR | 10/19/2022 | 000091953022000004 |
Q2 2022 | 157 | 623,153 | PFE, EMR, BMY, OGE | 13F-HR | 7/27/2022 | 000091953022000003 |
Q1 2022 | 168 | 721,724 | EMR, PFE, OGE, BMY | 13F-HR | 4/29/2022 | 000091953022000002 |
Q4 2021 | 162 | 727,098 | PFE, EMR, OGE, CSCO | 13F-HR | 1/26/2022 | 000091953022000001 |
Q3 2021 | 160 | 735,267 | EMR, PFE, OGE, VZ | 13F-HR | 11/2/2021 | 000091953021000004 |
Q2 2021 | 156 | 767,586 | EMR, OGE, BMY, PFE | 13F-HR | 7/23/2021 | 000091953021000003 |
Q1 2021 | 154 | 745,448 | EMR, GLW, BMY, INTC | 13F-HR | 4/22/2021 | 000091953021000002 |
Q4 2020 | 152 | 645,075 | EMR, BMY, GLW, PFE | 13F-HR | 2/5/2021 | 000091953021000001 |
Q3 2020 | 128 | 483,155 | EMR, BMY, GLW, PFE | 13F-HR | 11/6/2020 | 000091953020000005 |
Q2 2020 | 109 | 409,772 | EMR, BMY, PFE, GLW | 13F-HR | 7/29/2020 | 000091953020000004 |
Q1 2020 | 101 | 376,968 | EMR, BMY, GLW, PFE | 13F-HR | 4/14/2020 | 000091953020000003 |
Q4 2019 | 142 | 580,915 | EMR, BMY, GLW, PFE | 13F-HR | 1/29/2020 | 000091953020000002 |
Q3 2019 | 144 | 550,565 | EMR, XOM, GLW, BMY | 13F-HR | 10/21/2019 | 000091953019000009 |
Q2 2019 | 148 | 568,572 | EMR, XOM, GVA, GLW | 13F-HR | 8/2/2019 | 000091953019000007 |
Q1 2019 | 128 | 552,324 | EMR, XOM, GVA, GLW | 13F-HR | 4/30/2019 | 000091953019000005 |
Q4 2018 | 129 | 495,766 | EMR, XOM, GLW, PFE | 13F-HR | 1/29/2019 | 000091953019000003 |
Q3 2018 | 129 | 550,035 | XOM, EMR, GLW, PFE | 13F-HR | 11/2/2018 | 000091953018000015 |
Q2 2018 | 114 | 528,756 | XOM, EMR, JNJ, GLW | 13F-HR | 7/23/2018 | 000091953018000013 |
Q1 2018 | 114 | 517,174 | XOM, EMR, JNJ, GLW | 13F-HR | 4/19/2018 | 000091953018000011 |
Q4 2017 | 115 | 501,269 | EMR, XOM, JNJ, GLW | 13F-HR | 1/31/2018 | 000091953018000009 |
Q3 2017 | 109 | 512,870 | XOM, JNJ, EMR, GLW | 13F-HR | 11/3/2017 | 000091953017000008 |
Q2 2017 | 114 | 503,962 | JNJ, GLW, XOM, EMR | 13F-HR | 7/26/2017 | 000091953017000006 |
Q1 2017 | 117 | 483,675 | JNJ, GLW, XOM, EMR | 13F-HR | 4/25/2017 | 000091953017000003 |
Q4 2016 | 120 | 477,340 | JNJ, GLW, EMR, XOM | 13F-HR | 1/20/2017 | 000091953017000001 |
Q3 2016 | 116 | 486,246 | JNJ, GLW, EMR, XOM | 13F-HR | 10/20/2016 | 000091953016000028 |
Q2 2016 | 117 | 486,962 | JNJ, GLW, XOM, EMR | 13F-HR | 7/22/2016 | 000091953016000026 |
Q1 2016 | 105 | 426,210 | JNJ, GLW, XOM, EMR | 13F-HR | 4/27/2016 | 000091953016000023 |
Q4 2015 | 115 | 452,559 | JNJ, GLW, KO, XOM | 13F-HR | 2/11/2016 | 000091953016000021 |
Q3 2015 | 122 | 421,470 | JNJ, GLW, KO, XOM | RESTATEMENT | 10/23/2015 | 000091953015000019 |
Q2 2015 | 145 | 531,241 | JNJ, GLW, XOM, EMR | 13F-HR | 8/11/2015 | 000091953015000016 |
Q1 2015 | 141 | 526,156 | JNJ, GLW, XOM, EMR | 13F-HR | 5/13/2015 | 000091953015000008 |
Q4 2014 | 145 | 531,059 | JNJ, GLW, XOM, EMR | 13F-HR | 1/26/2015 | 000091953015000002 |
Q3 2014 | 148 | 519,857 | JNJ, XOM, GLW, EMR | 13F-HR | 11/12/2014 | 000091953014000015 |
Q2 2014 | 152 | 547,546 | JNJ, GLW, XOM, EMR | 13F-HR | 7/18/2014 | 000091953014000011 |
Q1 2014 | 147 | 539,890 | JNJ, GLW, XOM, EMR | 13F-HR | 5/7/2014 | 000091953014000008 |
Q4 2013 | 149 | 523,846 | JNJ, XOM, GLW, EMR | 13F-HR | 2/3/2014 | 000091953014000003 |